The global infant phototherapy devices market was valued at $71,730.23 thousand in 2016, and is expected to reach $103,744.71 thousand by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Phototherapy refers to the use of light for the treatment of jaundice in infants. It is one of the most common methods used to reduce the bilirubin (the compound that leads to jaundice) levels in infants. During phototherapy, an infant lies in a plastic crib, and is exposed to a type of light that is absorbed by its skin. During this process, the bilirubin in the baby's body is converted into a much simpler water-soluble form, which can be easily excreted through stool and urine.

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: INFANT PHOTOTHERAPY DEVICES MARKET, BY LIGHT SOURCE

CHAPTER 5: INFANT PHOTOTHERAPY DEVICES MARKET, BY CONFIGURATION

CHAPTER 6: INFANT PHOTOTHERAPY DEVICES MARKET, BY END USER

CHAPTER 7: INFANT PHOTOTHERAPY DEVICES MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES